Form 4: ClearPoint Neuro Director, R. John Fletcher, Acquires Shares as Compensation

Director R. John Fletcher acquired 850 shares of ClearPoint Neuro, Inc. as compensation under the company's Non-Employee Director Compensation Plan.

Summary

• On April 1, 2024, R. John Fletcher, a director of ClearPoint Neuro, Inc., acquired 850 shares of common stock.
• The shares were issued as payment for fees owed under the company's Non-Employee Director Compensation Plan.
• The price per share was $6.8, based on the closing price of ClearPoint Neuro's common stock on March 28, 2024.
• Following the transaction, Fletcher directly owns 74,797 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of director compensation. The transaction itself is neither particularly positive nor negative.

Positives

• The acquisition of shares by a director demonstrates alignment with the company's interests.

Industry Context

This is a routine disclosure of insider transactions, specifically related to director compensation in the form of company stock. It's common for companies to compensate directors with stock to align their interests with shareholders.

Related Party Transactions

• The issuance of shares to R. John Fletcher as compensation is a related party transaction.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a small number of shares issued as part of a compensation plan.

Key Dates